Decreased expression of CD44 splicing variants in advanced colorectal carcinomas

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1607-1611

  Weg Remers, S ^a   Anders, M ^b   Von Lampe, B ^b   Riecken, E O ^b   Schuder G ^a   Feifel, G ^a   Zeitz, M ^a   Stallmach, A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

CD44; Colorectal carcinoma; Metastasis; RT PCR; Tumour stage

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER STAGING; COLON MUCOSA; COLORECTAL CARCINOMA; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; ALTERNATIVE SPLICING; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BLOTTING, SOUTHERN; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032168184     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00177-4     Document Type: Article

References (25)

1. 1. Stauder R, Günthert U. CD44 isoforms. Impact on lymphocyte activation and differentiation. Immunologist 1995, 3, 78-83.
2. 2. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992, 89, 12160-12164.
3. 3. Günthert U, Hoffmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65, 13-24.
4. 4. Heider KH, Hofmann M, Hors W, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993, 120, 227-233.
5. 5. Wielenga VM, Heider KH, Offerhaus JA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumour progression. Cancer Res 1993, 53, 4754-4759.
6. 6. Imazeki F, Yokuzuka O, Yamaguchi T, Ohto M, Isono K, Omata I. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology 1996, 110, 362-368.
7. 7. Higashikawa K, Yokozaki H, Ue T, et al. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues. Int J Cancer 1996, 66, 11-17.
8. 8. Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrancois D, Theillet C. CD44 expression patterns in breast and colon tumours: a PCR-based study of splice variants. Int J Cancer 1995, 64, 347-354.
9. 9. Orzechowski HD, Beckenbach C, Herbst H, Stölzel U, Riecken EO, Stallmach A. Expression of human homologues of a metastasis-associated CD44 variant is associated with cellular dysplasia in colorectal epithelial cells. Eur J Cancer 1995, 31A, 2073-2079.
10. 10. Gorham H, Sugino T, Woodman AC, Tarin D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and normal colonic mucosa. J Clin Pathol 1996, 46, 482-488.
11. 11. Mulder JWR, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994, 344, 1470-1471.
12. 12. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Br Med J 1994, 308, 619-624.
13. 13. Beahrs OH. Colorectal cancer staging as a prognostic feature. Cancer 1992, 50, 2615.
14. 14. Dukas K, Sarfati P, Vaysse N, Pradayrol L. Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction. Anal Biochem 1993, 215, 66-72.
15. 15. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988, 263, 15335-15341.
16. 16. Finke LH, Terpe HJ, Zörb Q, Haensch W, Schlag PM. Colorectal cancer prognosis and expression of exon-v6-containing CD44-proteins. Lancet 1995, 345, 583.
17. 17. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996, 149, 873-882.
18. 18. Arch R, Wirth K, Hofmann M, et al. Participation in normal immune responses of a metastasis inducing splice variant of CD44. Science 1992, 257, 682-685.
19. 19. Koopman G, Heider KH, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993, 177, 897-904.
20. 20. Jalkanen S, Jalkanen M, Bargatze IR, Tammi M, Butcher EC. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 1988, 141, 1615-1623.
21. 21. Sherman L, Sleeman J, Dall P, et al. The CD44 proteins in embryonic development and in cancer. Current Top Microbiol Immunol 1996, 213, 249-269.
22. 22. Rosenberg WMC, Prince C, Kaklamanis L, et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 1995, 345, 1205-1209.
23. 23. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994, 124, 71-82.
24. 24. König H, Moll J, Ponta H, Herrlich P. Trans-acting factors regulate the expression of CD44 splice variants. EMBO J 1996, 15, 4030-4039.
25. 25. Screaton GR, Cáceres JF, Mayenda, A et al. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 1995, 14, 4336-4349.